The effects of MEK inhibition on mitochondrial physiology have been studied to a somewhat greater extent in the context of cancer biology, particularly in light of the fact that there is intense interest in developing cancer therapies that intentionally target cellular metabolism, including OxPhos(57–61). This evidence concerns the gene MAP2K7 and cancer.